BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30027379)

  • 1. Adjunctive interferon-γ immunotherapy in a pediatric case of Aspergillus terreus infection.
    Assendorp EL; Gresnigt MS; Sprenkeler EGG; Meis JF; Dors N; van der Linden JWM; Henriet SSV
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1915-1922. PubMed ID: 30027379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
    Hachem RY; Kontoyiannis DP; Boktour MR; Afif C; Cooksley C; Bodey GP; Chatzinikolaou I; Perego C; Kantarjian HM; Raad II
    Cancer; 2004 Oct; 101(7):1594-600. PubMed ID: 15378491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.
    Hachem R; Gomes MZ; El Helou G; El Zakhem A; Kassis C; Ramos E; Jiang Y; Chaftari AM; Raad II
    J Antimicrob Chemother; 2014 Nov; 69(11):3148-55. PubMed ID: 25006241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
    Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
    J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luliconazole, an alternative antifungal agent against Aspergillus terreus.
    Zargaran M; Taghipour S; Kiasat N; Aboualigalehdari E; Rezaei-Matehkolaei A; Zarei Mahmoudabadi A; Shamsizadeh F
    J Mycol Med; 2017 Sep; 27(3):351-356. PubMed ID: 28483449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus terreus Causing Probable Invasive Aspergillosis in a Patient with Cystic Fibrosis.
    Singh S; Kaur H; Singh M; Rudramurthy SM; Chakrabarti A
    Mycopathologia; 2019 Feb; 184(1):151-154. PubMed ID: 30168076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
    Lass-Flörl C; Griff K; Mayr A; Petzer A; Gastl G; Bonatti H; Freund M; Kropshofer G; Dierich MP; Nachbaur D
    Br J Haematol; 2005 Oct; 131(2):201-7. PubMed ID: 16197450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.
    Seyedmousavi S; Davis MJ; Sugui JA; Pinkhasov T; Moyer S; Salazar AM; Chang YC; Kwon-Chung KJ
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series.
    Delsing CE; Gresnigt MS; Leentjens J; Preijers F; Frager FA; Kox M; Monneret G; Venet F; Bleeker-Rovers CP; van de Veerdonk FL; Pickkers P; Pachot A; Kullberg BJ; Netea MG
    BMC Infect Dis; 2014 Mar; 14():166. PubMed ID: 24669841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis.
    Mokaddas E; Burhamah MHA; Ahmad S; Khan ZU
    J Med Microbiol; 2010 Dec; 59(Pt 12):1519-1523. PubMed ID: 20724511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi.
    Castón JJ; Linares MJ; Gallego C; Rivero A; Font P; Solís F; Casal M; Torre-Cisneros J
    Chest; 2007 Jan; 131(1):230-6. PubMed ID: 17218581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence within dendritic cells marks an antifungal evasion and dissemination strategy of Aspergillus terreus.
    Hsieh SH; Kurzai O; Brock M
    Sci Rep; 2017 Sep; 7(1):10590. PubMed ID: 28878289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal resistance in Aspergillus terreus: A current scenario.
    Vahedi Shahandashti R; Lass-Flörl C
    Fungal Genet Biol; 2019 Oct; 131():103247. PubMed ID: 31247322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal discitis due to Aspergillus terreus in a patient with acute lymphoblastic leukemia.
    Park KU; Lee HS; Kim CJ; Kim EC
    J Korean Med Sci; 2000 Dec; 15(6):704-7. PubMed ID: 11194199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of antifungal agents and human monocytes on in vitro galactomannan release by Aspergillus spp. in liquid culture medium.
    Winn RM; Warris A; Gaustad P; Abrahamsen TG
    APMIS; 2007 Dec; 115(12):1364-9. PubMed ID: 18184406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy.
    Anaissie EJ
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):683-90. PubMed ID: 19041608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
    Lahmer T; Messer M; Ehmer U; Eser S; Beitz A; Fekecs L; Schmid RM; Huber W
    Mycopathologia; 2016 Apr; 181(3-4):267-71. PubMed ID: 26455910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
    Steinbach WJ; Benjamin DK; Kontoyiannis DP; Perfect JR; Lutsar I; Marr KA; Lionakis MS; Torres HA; Jafri H; Walsh TJ
    Clin Infect Dis; 2004 Jul; 39(2):192-8. PubMed ID: 15307028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting
    Kumaresan PR; Wurster S; Bavisi K; da Silva TA; Hauser P; Kinnitt J; Albert ND; Bharadwaj U; Neelapu S; Kontoyiannis DP
    mBio; 2024 Apr; 15(4):e0341323. PubMed ID: 38415653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.
    Hope WW; Kruhlak MJ; Lyman CA; Petraitiene R; Petraitis V; Francesconi A; Kasai M; Mickiene D; Sein T; Peter J; Kelaher AM; Hughes JE; Cotton MP; Cotten CJ; Bacher J; Tripathi S; Bermudez L; Maugel TK; Zerfas PM; Wingard JR; Drusano GL; Walsh TJ
    J Infect Dis; 2007 Feb; 195(3):455-66. PubMed ID: 17205486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.